logo
IonQ Expands Across APAC Through Strategic Collaboration With Australian Company Emergence Quantum

IonQ Expands Across APAC Through Strategic Collaboration With Australian Company Emergence Quantum

Business Wire6 days ago
COLLEGE PARK, Md.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced a strategic collaboration with Emergence Quantum, an Australian research and development company focused on quantum hardware innovation. This initiative builds on IonQ's momentum in Australia and reinforces its commitment to advancing quantum innovation through strategic global partnerships.
The Emergence Quantum team has decades of experience, strong public and private sector relationships, and a deep understanding of the Australian and U.S. quantum tech landscapes. Former members of Microsoft's quantum team created the company to better harness their combined expertise in systems engineering, quantum control, and hardware integration.
Prof. David Reilly, Emergence Quantum CEO and co-founder, has held various positions at the University of Sydney, Harvard University, and the University of New South Wales. Prior to his current position, Prof. Reilly spent the previous eight years as a senior leader in Microsoft's quantum group. Co-founder Thomas Ohki, Emergence Quantum CTO/CSO, led the quantum group at Raytheon/BBN Technologies, joining with Reilly at Microsoft for several years prior to establishing Emergence.
As part of the collaboration, IonQ and Emergence Quantum will expand on existing advances in ion trap technology by co-developing next-generation electronics and materials. This includes the design and simulation of application-specific integrated circuits for qubit control. The teams will also work to reduce hardware complexity while scaling system capacity. Additionally, they will explore new materials and deposition techniques to enhance ion trap performance.
'This collaboration furthers IonQ's efforts to tap into one of the world's most promising quantum talent pools while contributing meaningfully to Australia's growing quantum industry,' said Dr. Dean Kassmann, SVP of IonQ's Engineering and Technology division. 'Our work with Emergence Quantum is part of a broader strategy to engage local experts and institutions around the world in advancing scalable, high-performance quantum computing and networking. This initiative will give IonQ significant access to a world-class team of Ph.D. quantum scientists that brings forward decades of experience in cryogenic electronics and quantum engineering.'
This work builds on IonQ's ongoing work in the region, including its collaboration with the Australian National University, and reflects the company's continued momentum in engaging with leading quantum research and talent ecosystems worldwide.
'We see tremendous demand in Australia for quantum technology so we are delighted to partner with IonQ to advance quantum innovation in the country,' said Prof. Reilly. 'The challenge in Australia has always been how to bring in international investment, without losing the key know-how and talent that we have here. Collaborating with IonQ allows us to accelerate the pace of Australia's quantum development and growth.'
About IonQ
IonQ, Inc. [NYSE: IONQ] is a leading commercial quantum computing, quantum networking, and quantum applications company, delivering high-performance systems aimed at solving the world's most complex problems. IonQ's current generation quantum computers, IonQ Forte and IonQ Forte Enterprise, are the latest in a line of cutting-edge systems that have been helping customers and partners such as Amazon Web Services, AstraZeneca, and NVIDIA achieve 20x performance results.
The company is accelerating its technology roadmap and intends to deliver the world's most powerful quantum computers with 2 million qubits by 2030 to accelerate innovation in drug discovery, materials science, financial modeling, logistics, cybersecurity, and defense. IonQ's advancement in quantum networking also positions the company as a leader in building the quantum internet.
The company's innovative technology and rapid growth were recognized in Newsweek's 2025 Excellence Index 1000, Forbes' 2025 Most Successful Mid-Cap Companies list, and Built In's 2025 100 Best Midsize Places to Work in Washington DC and Seattle, respectively. Available through all major cloud providers, IonQ is making quantum computing more accessible and impactful than ever before. Learn more at IonQ.com.
About Emergence Quantum
Emergence Quantum is a team of globally recognised scientists and engineers delivering integrated hardware platforms and the foundational technology underpinning quantum, future energy-efficient computing, and advanced sensing interfaces, with a focus on integration and co-designed solutions. Expertise spans the fundamental physics of semiconductor and superconducting devices to the engineering challenges of complex, scaled-up computing and sensing platforms. A central theme of Emergence Quantum's work is the use of integrated cryogenic electronics to address critical challenges in scaling quantum computers, as well as enabling new computational and sensing modalities.
IonQ Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Some of the forward-looking statements can be identified by the use of forward-looking words. Statements that are not historical in nature, including the words 'accelerating,' 'accessible,' 'advance,' 'advancement,' 'advancing,' 'aimed,' 'building,' 'builds,' 'can,' 'co-developing,' 'collaboration,' 'commitment,' 'contributing,' 'delivering,' 'engage,' 'explore,' 'initiative,' 'intends,' 'momentum,' 'next-generation,' 'scale,' 'will,' and other similar expressions are intended to identify forward-looking statements. These statements include those related to the IonQ's quantum computing and networking capabilities and plans; IonQ's technology delivering scalable, fault-tolerant quantum computing in the future; the relevance and utility of quantum algorithms and applications run on IonQ's quantum computers; the future impacts of IonQ's offerings available today and in the future; and the scalability, fidelity, efficiency, viability, accessibility, effectiveness, importance, reliability, performance, speed, impact, practicality, feasibility, and commercial-readiness of IonQ's offerings. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: IonQ's ability to implement its technical roadmap; changes in the competitive industries in which IonQ operates, including development of competing technologies; IonQ's ability to deliver, and customers' ability to generate, value from IonQ's offerings; IonQ's ability to deliver next-generation electronics and materials, reduce hardware complexity, scale system capacity, and enhance system performance, information transfer, and network accuracy, or reduce noise and errors; IonQ's ability to sell effectively to government entities and large enterprises; changes in laws and regulations affecting IonQ's and its suppliers' businesses; IonQ's ability to implement its business plans, forecasts, roadmaps and other expectations, to identify and realize partnerships and opportunities, and to engage new and existing customers; IonQ's ability to effectively enter new markets; IonQ's ability to deliver services and products within currently anticipated timelines; IonQ's inability to attract and retain key personnel; IonQ's inability to effectively integrate its acquisitions of Qubitekk, Inc., Lightsync Technologies, Inc., and Capella Space Corporation and close its acquisitions of Oxford Ionics Limited and ID Quantique, SA; IonQ's customers deciding or declining to extend contracts into new phases; the inability of IonQ's suppliers to deliver components that meet expectations timely; changes in government spending or policy that may affect IonQ's customers; and risks associated with government sales, including availability of funding and provisions that may allow the government to unilaterally terminate or modify contracts for convenience; changes in laws and regulations affecting IonQ's patents; and IonQ's ability to maintain or obtain patent protection for its products and technology, including with sufficient breadth to provide a competitive advantage. You should carefully consider the foregoing factors and the other risks and uncertainties disclosed in the Company's filings, including but not limited to those described in the 'Risk Factors' section of IonQ's filings with the U.S. Securities and Exchange Commission, including but not limited to the Company's most recent Annual Report on Form 10-K and reports on Form 10-Q. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and IonQ assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. IonQ does not give any assurance that it will achieve its expectations. IonQ may or may not choose to practice or otherwise use the inventions described in the issued patents in the future.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Revvity Inc (RVTY) Q2 2025 Earnings Call Highlights: Strong Software Growth and Strategic Share ...
Revvity Inc (RVTY) Q2 2025 Earnings Call Highlights: Strong Software Growth and Strategic Share ...

Yahoo

time9 minutes ago

  • Yahoo

Revvity Inc (RVTY) Q2 2025 Earnings Call Highlights: Strong Software Growth and Strategic Share ...

Revenue: $720 million in Q2, 3% organic growth. Adjusted EPS: $1.18, above expectations. Life Sciences Segment Growth: 4% organic growth. Diagnostics Segment Growth: 2% organic growth. Signals Software Growth: Over 30% organic growth. Free Cash Flow: $115 million in Q2, 83% conversion of adjusted net income. Operating Margin: 26.6% adjusted operating margin, down 210 basis points year over year. Share Repurchase: $293 million worth of shares repurchased in Q2. Full-Year Organic Growth Outlook: 2% to 4% range. Full-Year Adjusted EPS Outlook: $4.85 to $4.95. Net-Debt-to-Adjusted-EBITDA Ratio: 2.6 times. Adjusted Tax Rate: 19.1% in Q2. Warning! GuruFocus has detected 5 Warning Signs with RVTY. Release Date: July 28, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Revvity Inc (NYSE:RVTY) achieved 3% organic growth in Q2 2025, in line with expectations, driven by strong performance in the Life Sciences segment. The Signals Software franchise experienced approximately 30% growth, setting a new record for orders in a single quarter. Revvity Inc (NYSE:RVTY) reported adjusted EPS of $1.18, which was above expectations and guidance. The company generated $115 million in free cash flow during the quarter, maintaining a solid 90% conversion rate year-to-date. Revvity Inc (NYSE:RVTY) repurchased nearly $300 million worth of stock in Q2, bringing total repurchases to nearly $450 million for the first half of the year. Negative Points The Diagnostics segment faced challenges in China due to changes in hospital lab reimbursement policies, impacting the Immunodiagnostics business. Revvity Inc (NYSE:RVTY) lowered its full-year organic growth outlook to 2% to 4%, down 1% from prior expectations. The company anticipates a meaningful pullback in its Immunodiagnostics business in China for the remainder of the year. Operating margins were pressured by lower volumes of high-margin diagnostic tests and recent changes in FX rates. The academic and government customer segment continued to show weakness, with revenue declining in the low single digits year over year. Q & A Highlights Q: Can you explain the guidance change related to organic growth, particularly in China, and whether other factors like VBP are involved? A: (Prahlad Singh, CEO) The majority of the impact is from the DRG policy in China, which affects multiplex tests. This policy reduces test volumes, but in the long term, it may lead to more single-plex tests, which are more expensive. We are working with stakeholders to potentially reverse these changes due to their impact on patient care. Q: Regarding margin changes, what are your expectations for 2026 margins, and what growth assumptions are they based on? A: (Maxwell Krakowiak, CFO) We expect a baseline operating margin of 28% for 2026, with margin expansion depending on organic growth levels. Typically, with high single-digit growth, we expect a 75 basis point margin expansion, and with mid-single-digit growth, about 50 basis points. Q: What are the revenue pacing assumptions for this year, and how do you see the impact of NIH funding and year-end budget flush? A: (Maxwell Krakowiak, CFO) We expect normal seasonality with a high single-digit ramp in both Life Sciences and Diagnostics. The fourth quarter will see a ramp-up in gel and larger volume in Signals Software. We assume academic and government funding will remain weak for the rest of the year. Q: Can you provide insights into the Life Sciences segment's performance, particularly reagents and instruments, and any guidance changes? A: (Prahlad Singh, CEO) Pharma-biotech showed stability with mid-single-digit growth, and our Life Sciences reagents business has grown for five consecutive quarters. While capital equipment spending is impacted, we remain optimistic about the reagents business. Q: How is the Software segment performing, and what are the expectations for growth in the second half? A: (Prahlad Singh, CEO) The Signals Software business had a record quarter with 32% organic growth. We focus on net retention, ARR, and APV, with strong SaaS bookings. We expect continued growth due to investments and new product launches. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Walmart Stock (WMT) Widening Gap on Rivals Despite Holiday Price Hikes Ahead
Walmart Stock (WMT) Widening Gap on Rivals Despite Holiday Price Hikes Ahead

Business Insider

time37 minutes ago

  • Business Insider

Walmart Stock (WMT) Widening Gap on Rivals Despite Holiday Price Hikes Ahead

Shares in U.S. retail giant Walmart (WMT) were marked higher today as it said it expects to gain market share from tariff turmoil this year. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Market Share According to a note from analysts at Jefferies, even though Walmart has already raised prices on a range of goods given the uncertainty around President Trump's tariffs, it still expects to gain market share from its peers. Following a recent meeting with Walmart's head of investor relations, Steph Wissink, Jefferies said in a note that 'prices increased as the tariffs were implemented in April' for perishables and other items sourced from Central America. The firm noted that in June, prices also began to rise on 'infrequently purchased general merchandise items that were previously trending deflationary.' Such macro risks are key for consumer-facing stocks like Walmart as one can see below. Value Focus Jefferies said Walmart (NYSE:WMT) expects further increases on 'seasonal items heading into Halloween and the winter holidays,' but remains committed to its value-focused strategy: 'WMT remains committed to its Everyday Low Price strategy and taking less price than its peers,' it said. Despite inflationary pressures, Jefferies said Walmart believes that the U.S. consumer has been relatively resilient. 'We would categorize the US consumer as consistent,' said Jefferies, though Walmart has seen 'emerging signs of trade down and substitution.' It is understood that Walmart plans to aggressively compete during the upcoming back-to-school season by 'widening its price gaps on key, high-frequency items,' which it expects will boost share as consumers become more price-sensitive. Walmart is already performing well against its peers as can be seen below. In terms of inventory, Jefferies said Walmart expects it to jump in the second quarter given that the 'actual tariff rate is higher than originally expected.' However, analysts said they are 'not concerned about the health of the inventory.' Jefferies expects the company to reaffirm its full-year outlook, stating, 'We believe that WMT is well-positioned to achieve its guidance,' even as tariff-related volatility limits near-term upside. Jefferies has a Buy rating on the stock and a $120 price target. Is WMT a Good Stock to Buy Now? On TipRanks, WMT has a Strong Buy consensus based on 28 Buy ratings. Its highest price target is $120. WMT stock's consensus price target is $111.33, implying a 14.06% upside.

How The J. M. Smucker Company (SJM) Fits into the Food Dividend Stock Portfolio
How The J. M. Smucker Company (SJM) Fits into the Food Dividend Stock Portfolio

Yahoo

time38 minutes ago

  • Yahoo

How The J. M. Smucker Company (SJM) Fits into the Food Dividend Stock Portfolio

The J. M. Smucker Company (NYSE:SJM) is included among the 10 Best Food Stocks with Dividends. A wholesaler distributing peanut butter, fruit spreads and specialty spreads to a retailer. The J. M. Smucker Company (NYSE:SJM) is recognized as a strong value in the food sector, with several successful brands under its belt. Notable performers include pet food lines like Meow Mix and Milk-Bone, as well as the well-liked Uncrustables sandwich products. The company paid a premium when it acquired Hostess Brands in November 2023. To refocus its efforts, the company recently sold off some brands from its Sweet Baked Snack segment, including Voortman, to concentrate more on the Hostess portfolio. Although the transition has been challenging, The J. M. Smucker Company (NYSE:SJM) appears to be moving in the right direction. It anticipates full-year fiscal 2026 sales to grow by 2% to 4%, despite the effects of divesting certain Sweet Baked Snack value brands. The company is also expected to deliver strong earnings and free cash flow. In fiscal Q4 2025, The J. M. Smucker Company (NYSE:SJM) reported operating cash flow of $393.9 million, and its free cash flow was $298.9 million. During the quarter, the company returned $114.5 million to shareholders through dividends, reinforcing its commitment to investor return. This cash position enables the company to consistently raise its dividends. The J. M. Smucker Company (NYSE:SJM) declared a 1.9% hike in its quarterly dividend on July 16. This marked the company's 24th consecutive year of dividend growth, which makes it one of the best food stocks with dividends. The company now offers a quarterly dividend of $1.10 per share and has a dividend yield of 4.04%, as of July 27. While we acknowledge the potential of SJM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: READ NEXT: and Disclosure: None. 登入存取你的投資組合

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store